No Data
No Data
A. G. P. Initiates Evogene(EVGN.US) With Buy Rating, Announces Target Price $2.25
A. G. P. analyst Scott Henry initiates coverage on $Evogene(EVGN.US)$ with a buy rating, and sets the target price at $2.25.According to TipRanks data, the analyst has a success rate of 40.0% and a to
Evogene Subsidiary Casterra Ag Expands Into Africa With $440K Castor Seed Order
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
Evogene Innovates With AI in Life-Sciences
Earnings Call Summary | Evogene(EVGN.US) Q1 2024 Earnings Conference
Biomica Presents Positive Clinical Data Update From Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma